Sun Healthcare Group SUNH will report fourth quarter earnings after the market close next Tuesday, March 1. Morgan Keegan's EPS estimate of $0.37 is $0.01 below the First Call consensus and up from $0.28 in the prior year period.
Morgan Keegan's investment thesis for skilled nursing facility operators is that the new RUG-IV Medicare reimbursement system is favorable and will drive profitability in 2011. Morgan Keegan expects Sun to report strong results.
Morgan Keegan believes Sun Healthcare Group can sustain above-average growth by increasing its medically complex Medicare and managed care census, providing higher-acuity short-stay services, improving operating efficiency, generating cash to pay down debt, and making selective accretive acquisitions. It expects Sun to benefit from recent changes to Medicare reimbursement.
Morgan Keegan has a $17 PT and Outperform rating on SUNH
SUNH closed Friday at $14.74
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in